ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
92,800
-1,900 (-2.01%)
Aug 29, 2025, 9:40 AM KST

ABL Bio Market Cap

ABL Bio has a market cap or net worth of 5.17 trillion as of August 28, 2025. Its market cap has increased by 256.77% in one year.

Market Cap
5.17T
Enterprise Value
5.08T
Revenue
94.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
92,800.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 5.17T, an increase of 749.19%. That is a compound annual growth rate of 37.66%.

History

DateMarket Cap% Change
Aug 27, 20255,173.72B258.38%
Dec 30, 20241,443.63B22.53%
Dec 28, 20231,178.16B7.19%
Dec 29, 20221,099.13B5.54%
Dec 30, 20211,041.42B-27.59%
Dec 30, 20201,438.26B31.46%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 19, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics72.53T
Celltrion37.63T
ALTEOGEN22.61T
Yuhan8,730.14B
SK Biopharmaceuticals7,878.31B
PharmaResearch7,314.31B
Peptron7,303.72B
LigaChem Biosciences5,379.81B
Market Cap Rankings